Fetal hemoglobin increases safely with increased hydroxyurea in infants with sickle cell anemia
Meghna Dua, MD, Department of Global Pediatric Medicine, St. Jude Children’s Research Hospital, presented data from her team’s findings regarding hydroxyurea dosing in very young children with sickle cell disease (SCA) during the American Society of Hematology (ASH) Annual Meeting and Exposition. With little published research on infants’ tolerance to hydroxyurea dose escalation, Dua and …
